Airway remodeling is resultant
BMS345541. Acute poly(I:C) exposure in vivo induced profound neutrophilic airway inflammation. When administered repetitively, poly(I:C) resulted in enhanced fibrosis observed by lung micro-computed tomography, second harmonic generation microscopy of optically cleared lung tissue, and by immunohistochemistry. Epithelial flattening, expansion of the epithelial mesenchymal trophic unit, and enhanced Snail family zinc finger 1 and fibronectin 1 expression in airway epithelium were also observed. Repetitive poly(I:C)-induced airway remodeling, fibrosis, and epithelial-mesenchymal transition was inhibited by BMS345541 administration. Based on this novel model of viral inflammation-induced remodeling, we conclude that NF-kB is a major controller of epithelial-mesenchymal transition and pulmonary fibrosis, a finding that has potentially important relevance to airway remodeling produced by repetitive viral infections.
Keywords: airway reprogramming; polyinosinic:polycytidylic acid; Toll-like receptor 3; epithelial-mesenchymal transition; tissue clearing Asthma is a chronic inflammatory disorder of the airways manifested by reversible episodic bronchoconstriction, triggered by environmental and infectious stimuli. Over 300 million adults and children suffer from this disease, making this an important public health problem (1) . Asthma represents a constellation of phenotypes, due to complex gene-environmental interactions. Although bronchoconstriction is typically reversible, a subset of subjects with asthma develop progressive decline in pulmonary function with age, a process thought to be due to irreversible airway remodeling and fibrosis (2) . Similarly, airway remodeling is linked to progressive declines in airway function seen in patients with chronic airway disease, including chronic obstructive pulmonary disease and cystic fibrosis (3, 4) .
Airway remodeling is a constellation of structural changes that includes disruption of the epithelial barrier function, subepithelial fibrosis, myofibroblast hyperplasia, and smooth muscle hypertrophy (2, 5) . Although airway remodeling is a complex, multicellular phenomenon triggered by environmental, age-related, and genetic factors (6), we now know that chronic epithelial injury can play a fundamental role. In this case, disruption of the epithelial barrier induces secretion of epithelial growth factors (transforming growth factor [TGF]-b, epidermal growth factor) and cytokines (periostin, IL-17, IL-11) that initially promote reepithelialization and fibrosis, initial stages important in mucosal repair (7) . Although this process initially plays a homeostatic function in mucosal injury, its prolonged action is associated with organ fibrosis and progressive decline in lung functions in a subset of patients who suffer its unremitting effects (8) .
The signal transduction pathway triggered by TGF-b through its type II receptor (TGF-bRII) is now well understood and known to be an important part of the epithelium-associated remodeling process. TGF-bRII activates epithelial programs through interacting Smad-dependent and Smad-independent pathways (9); these pathways converge on activating the transcriptional corepressor, Snail family zinc finger (SNAI) 1. SNAI1, in turn, directly binds to regulatory promoter regions of E-cadherin (CDH1) and zona occludens-1, leading to their repression and subsequent cellular loss of apical-basal polarity (10) . Separately, SNAI1 upregulation induces zinc finger E-box binding homeobox (ZEB) 1, a separate epithelial-mesenchymal transition (EMT) core regulator, to produce a multistep dedifferentiation program referred to as type II EMT (11) . In this manner, TGF-b induces epithelial cells to express mesenchymal smooth muscle cell actin and intermediate filament vimentin (VIM), enhancing motility, and secrete collagen (COL), fibronectin (FN), and matrix metalloproteinases, promoting extracellular matrix deposition (12) . Consequently, this response promotes airway remodeling with expansion of the smooth muscle cell layer, repair of the epithelial surface, and, ultimately, interstitial fibrosis (11, 13) . Clinically, features of mesenchymal transition have been observed in subsets of subjects with severe asthma and chronic obstructive pulmonary disease (COPD) with remodeling; however, the role of mesenchymal transition has yet to be fully established (7, 9, 14) .
Epidemiological studies have shown that recurrent viral airway infections are the most common cause of exacerbations in obstructive lung diseases (2, (15) (16) (17) (18) ; these infections lead to an accelerated decline in lung function through poorly defined mechanisms (19) . The epithelium plays a major role in the response to mucosal viruses by pattern-recognition receptor-induced innate response, producing inflammation and antiviral responses (20) . Recently, we used unbiased gene expression profiling studies to identify a central role of the NF-kB transcription factor in the TGF-b-induced type II EMT gene program through its ability to directly trigger expression of SNA1, FN1, and the IL-6 growth factor (21) . These studies indicated a direct, molecular link between innate inflammation and airway fibrosis (13, 21) .
Reasoning that NF-kB activation may be sufficient to activate the EMT program, we examined the role of NF-kB activation by chronic activation of the innate response in vitro and in vivo. We describe here that chronic stimulation of primary human airway epithelial cells with the doublestranded RNA mimic and Toll-like receptor (TLR) 3 agonist (22) , polyinosinic: polycytidylic acid (poly[I:C]), induced a time-dependent expression of NF-kB, EMT regulators, and the fibrotic program. Repetitive intranasal poly(I:C) administration in vivo induced morphological changes of airway epithelial cells in the conductive airways, with evidence of enhanced fibrosis in medium and small airways. These changes were associated with proximal and small-airway epithelial expression of SNA1, FN1, and COL1A, indicating mesenchymal transition. The remodeling and fibrotic program was completely inhibited by administration of the highly selective smallmolecule IkB kinase (IKK) inhibitor. These data provide a new model for the study of innate inflammation-associated airway fibrosis and mechanistic insights into the role of the IKK-NF-kB pathway in epithelial cell state changes.
Materials and Methods
Detailed MATERIALS AND METHODS are available in the online supplement.
Results

Persistent TLR3 Pathway Activation Induces Mesenchymal Transition of Airway Epithelial Cells
In this study, we investigated the effects of poly(I:C) on EMT in telomeraseimmortalized primary cultures of human small-airway epithelial cells (hSAECs) (13, 21, 23, 24) . We selected hSAECs for our in vitro studies, because they maintain a stable epithelial morphology, express differentiated airway epithelial cytokeratin isoforms after hundreds of population doublings, form pseudostratified columnar epithelium in air-liquid interfaces, and support the replication of mucosalrestricted viruses (25) (26) (27) . Unbiased wholegenome studies show that these cells maintain gene expression patterns of primary cells (23) . Similarly, proteomics profiling indicated that these cells secrete cytokeratin patterns and viral-induced inflammatory protein patterns that faithfully reproduce explants of primary human small-airway cells (24) . Moreover, these cells have a functional NF-kB signaling pathway linked to TGFb-induced mesenchymal transition (21) ,
Clinical Relevance
Airway remodeling causes a progressive decline of pulmonary function in patients with obstructive lung disease. Airway remodeling is caused by respiratory virus infections through largely unknown mechanisms. Our study demonstrates that repetitive activation of viral response pathways produces inflammation, mesenchymal transition of epithelial surface, and fibrosis. Our studies implicate the NF-kB pathway in the mediation of this process, identifying NF-kB as a target for reducing inflammationmediated remodeling.
and therefore have many characteristics representative of primary lower-airway epithelial cells.
We observed that extracellular poly(I:C) stimulation rapidly activated NF-kB/RelA nuclear translocation in confocal immunofluorescence (IF) assays ( Figure 1A ). By contrast, chronic poly(I:C) stimulation induced hSAECs to assume an elongated shape with markedly reorganized stress fibers extending throughout the cytoplasm over a wide concentration range (1-50 mg/ml) ( Figure 1B ). This morphological change of enhanced front-rear polarity and actin rearrangement are characteristic morphological changes of epithelial dedifferentiation produced by the TGF-b-induced EMT program ( Figure 1B) (13, 21) .
IF microscopy was used to further evaluate this cell state change. In untreated hSAECs, CDH1 is detectable in the periphery of the cytoplasm/cell junctions and in cytoplasmic aggregates, whereas VIM staining is faintly detectable in the cytoplasm ( Figure 1C ). There were low levels of SNAI1 expression in punctate foci within the nucleus, and RelA was located within the cytoplasm, characteristic of its inactive state. By contrast, in poly(I:C)-stimulated cells, CDH1 expression was no longer detectable, and intense VIM staining was seen in organized cytoplasmic bundles ( Figure 1C ). SNAI1 staining was increased throughout the cell, particularly in the nucleus. These staining patterns are similar to those of TGF-b-induced EMT ( Figure 1C ). Importantly, in RelA, nuclear translocation is observed in response to both EMT activating stimuli. The pathways controlling NF-kB activation in response to TGF-b have been partially investigated (21, 28) . These data indicate that chronic poly(I:C) stimulation induces typical cellular features of EMT. Figures  1A and 1C) . To identify whether the EMT gene program was activated, we observed that repetitive, short-term poly(I:C) stimulation (for 1 h daily) would downregulate the epithelial marker, CDH1, and/or up-regulate the mesenchymal markers, VIM and SNAI1 (Figure 2A ). Because both repetitive daily stimulation and tonic stimulation with poly(I:C) produced similar effects on the mesenchymal transition, for convenience, in subsequent experiments we stimulated hSAECs tonically with poly(I:C).
To determine whether RelA was functionally required for the mesenchymal transition, we examined the effect of NF-kB/RelA silencing using doxycycline To examine whether this level of silencing interfered with the NF-kB expression program, RelA-shRNA hSAECs were poly(I:C) stimulated in the presence or absence of Dox, and changes in NF-kB-dependent genes measured by quantitative RT-PCR. In wild-type cells, poly(I:C) induced the NF-kB-dependent TNF alpha induced protein 3 (TNFAIP3)/ A20 gene by roughly 135-fold after 1 day, which monotonically fell to less than 20-fold after 9 days of stimulation. TNFAIP3/A20 mRNA expression was significantly blocked by RelA silencing at all time points ( Figure 2C ). Poly(I:C) produced a 350-fold up-regulation of IL-6. Although the initial peak of up-regulated IL-6 expression was slightly delayed relative to that of TNFAIP3/A20, RelA knockdown also significantly blocked poly(I:C)-induced NF-kB-dependent IL-6 expression ( Figure 2C ). Together, these data indicate that the RelA shRNA silencing was functionally effective in blocking expression of its downstream genes.
We next examined the NF-kB dependence on poly(I:C)-induced expression of mesenchymal and fibrotic genes. In wild-type cells, CDH1 mRNA expression fell to 80% after 1 day of poly(I:C) treatment, and continued to fall to approximately 30% 9 days after treatment ( Figure 2C ), a pattern consistent with the TGF-b-induced loss of differentiated epithelial marks (9) . This inhibition was partially reversed by the RelA silencing, where CDH1 mRNA levels fell to approximately 80% after 9 days of poly(I:C) treatment (P , 0.01, ANOVA). We also noted that the monophasic induction of the mesenchymal fibrotic genes, FN1, COL1A1, and VIM, by poly(I:C) over the course of stimulation was blocked by RelA silencing ( Figure 2C ). Finally, poly(I:C)-induced expression of mRNA of the core EMT regulators, SNAI1 and ZEB1, was also blocked by RelA silencing. Consistent with our earlier observations of TGF-b-induced mesenchymal transition, SNAI1 mRNA was the most rapidly and highly activated core EMT regulator, peaking within 3 days of stimulation at 17-fold over controls, whereas ZEB1 mRNA exhibited a lower magnitude of induction ( Figure 2C ). Importantly, the poly(I:C) induction of SNAI1 and ZEB1 mRNA was significantly inhibited by RelA knockdown ( Figure 2C ).
To further explore the role of NF-kB pathway, hSAECs were treated in the absence or presence of an IKK inhibitor (BMS345541) and stimulated with poly(I:C) for up to 9 days. We observed that BMS345541 inhibited the poly(I:C)-induced expression of the VIM mesenchymal genes and SNAI1 and ZEB1 core EMT regulators ( Figure 2D ). Together, these data indicate the central role of the IKK-NF-kB/RelA pathway in poly(I:C)-induced mesenchymal transition in airway epithelial cells. These data indicate that chronic poly(I:C) stimulation induces the mesenchymal transition, and that the IKK-NF-kB/RelA pathway is upstream of the gene regulatory network controlling fibrosis.
Acute Exposure to Poly(I:C) Induces NF-kB-IKK-Dependent Neutrophilic Inflammation in Airways
We first determined the effect of IKK inhibition on acute poly(I:C)-induced airway neutrophilic inflammation. C57BL6/J mice pretreated with or without BMS345541 were challenged with intranasal poly(I:C). We observed that poly(I:C) induced a profound accumulation of neutrophils around the small-and medium-sized airways 24 hours after intranasal poly(I:C) challenge ( Figure 3A ) that was completely inhibited by BMS345541 administration. The total number of bronchoalveolar lavage fluid (BALF) cells increased nearly four times over that of PBS-treated mice, an induction completely inhibited by BMS345541 treatment ( Figure 3B , left panel). In addition, the percentage of BALF neutrophils increased from 1 to 61.3% in PBS-treated mice exposed to poly(I:C), an effect reduced to 6.3% in BMS345541-treated mice ( Figure 3B ).
Correspondingly, poly(I:C) induced dramatic inductions of inflammatory cytokine levels measured in the BALF. In comparison to PBS-treated mice, IL-6 protein abundance was below the lower limit of detection (LLOD); poly(I:C) increased IL-6 from its LLOD to 632 pg/ml ( Figure 3C ). Similar poly(I:C)-induced expression patterns were seen for keratinocyte chemoattractant (KC), increasing to 791 pg/ml, monocyte chemoatractant protein-1 (MCP-1) to 4,962 pg/ml, granulocyte/macrophage colony-stimulating factor to 2,000 pg/ml, macrophage inflammatory protein-1b (MIP-1b) to 500 pg/ml, and regulated upon activation, normal T cell expressed and secreted to 1,793 pg/ml from their LLOD ( Figure 3C ). In the BMS345541-treated animals, poly(I:C)-induced values were reduced by over 95%, nearly to those of PBS-challenged mice ( Figure 3C ). Together, these data indicate that NF-kB is required for TLR3-induced activation of the innate immune response and airway neutrophilia. Reasoning that persistent TLR3 activation induces EMT in hSAECs (Figures 1 and 2) , and that EMT may be associated with airway remodeling, we asked whether repetitive TLR3 activation would produce airway remodeling/fibrosis in vivo. Mice were repetitively challenged with intranasal poly(I:C) for 15 challenges, followed by a 12-day rest period (Figure 4A ). To assess the role of NF-kB-IKK pathway in the tissue response, parallel groups were treated with BMS345541 before intranasal poly(I:C) challenge. We observed that the poly(I:C)-challenged mice lost 25% body weight compared with PBS-challenged mice, an effect that was prevented by BMS345541 treatment ( Figure 4B ).
Micro-computed tomography (micro-CT) imaging was performed to evaluate the presence of remodeling/fibrosis. These micro-CT images revealed infiltrates of dense matter, predominately in the left lobes of chronic poly(I:C)-treated mice, whereas the lungs of poly(I:C)-challenged mice pretreated with BMS345541 showed density similar to that seen in controls ( Figure 4C) . Quantification of the percentage of dense sectional area of these mice revealed the same findings ( Figure 4D ). Three-dimensional (3D) reconstruction of the lung parenchyma showed loss of airspace in the left upper lobe and left lower lobe ( Figure 4E ). Representative lungs from each treatment group were scanned ex vivo under conditions that provided better dynamic contrast. These images demonstrated the normal airway structure in the lungs of PBS-treated mice, whereas, in chronic poly(I:C)-challenged mice, the airway structure showed significant pulmonary fibrosis in the medium and small airways ( Figure 4F ).
To quantitatively assess the degree of fibrosis in intact lungs, we used a tissueclearing technique to optically clear lung tissue, coupled with application of second harmonic generation microscopy (SHGM), a nonlinear optical microscopy technique for visualization and quantification of COL accumulation in the tissue ( Figure 5A ). We found that chronic poly(I:C) challenge induced a sevenfold increase of COL accumulation around the airways as compared with that of PBS-treated mice. COL accumulation in airway of poly(I:C)-challenged mice pretreated with BMS345541 showed comparable COL content to those controls challenged with PBS ( Figure 5B) .
Using a tiling approach of SHGM images, we created a 3D volume map of COL distribution concentrating on small airways ranging from 100-300 mm in diameter. The 3D volume map demonstrates the poly(I:C)-induced COL accumulation throughout the interstitial space surrounding these small-and medium-sized airways (shown in green, Figure 5C ). To further demonstrate global airway fibrosis biochemically, we quantified COL abundance by assaying hydroxyproline content in the whole lungs and BALF. Poly(I:C) administration induced an approximately twofold increase in both total lung and BALF hydroxyproline abundance, an increase completely blocked in the BMS345541-treated animals ( Figure 5D ). Together, the results of the SHGM, micro-CT scan, and whole-lung COL content analyses clearly indicate that chronic poly(I:C) treatment induces airway remodeling and pulmonary fibrosis in vivo, and its effect could be abolished by inhibition of the IKK-NF-kB pathway.
IKK-NF-kB Pathway Mediates Chronic Poly(I:C)-Induced Airway Remodeling and Fibrosis
Examination of histopathological changes using light microscopy indicated that repetitive poly(I:C) treatment induced marked subepithelial fibrosis with enhanced COL distribution throughout the parenchyma ( Figure 6A , COL in blue). The epithelium was flattened with loss of its brush-border appearance, and there were enhanced numbers of glandular cells. At higher power, we observed expansion of mesenchymal supporting cells, suggesting expansion of the epithelial-mesenchymal trophic unit (EMTU; black arrow, Figure 6A ) and thickening of the alveolar septae. By contrast, the lungs of animals treated with BMS345541 were histologically normal, consistent with our earlier micro-CT and SHGM analysis indicating that IKK inhibition effectively blocked poly(I:C)-induced airway fibrosis ( Figure 6A ). The average combined Ashcroft score in poly(I:C) treatment was 9 (n = 5 mice), indicating a moderate level of pulmonary fibrosis, whereas the combined Ashcroft score in poly(I:C) 1 BMS345441-treated mice was significantly lower, at a value of 1 (P , 0.01, n = 5, Figure 6B ). Unlike what we found in acute poly(I:C) exposure, the number of BALF leukocytes were similar in all the treatment groups, indicating that the acute inflammation had subsided ( Figure 6C ).
The levels of IL-6, KC, and regulated upon activation, normal T cell expressed and secreted in BALF were induced in the poly(I:C)-treated mice, and reduced by BMS345541 treatment ( Figure 6D ). There were no changes in MCP-1 ( Figure 6D ). We also noted that these cytokine levels were significantly lower than that of mice in response to acute poly(I:C) exposure (compare Figures 3 and 6D) , indicating that chronic poly(I:C) challenge induced activation of the innate immune response, and that neutrophilia had largely abated during the 12-day rest period incorporated in to our experimental design ( Figure 4A ).
IKK-NF-kB Pathway Mediates Chronic Poly(I:C) Treatment-Induced EMT
To more precisely determine the presence of EMT and effect of BMS345541 on this process, IF stainings for the mesenchymal markers, SNAI1, VIM, COL1A, and FN1, were conducted. Only faint staining of SNAI1, VIM, FN1, and COL1A was detected in control airways ( Figure 7A and Table 1 ). In contrast, chronic poly(I:C) induced enhanced staining of SNAI1, VIM, FN1, and COL1A ( Figure 7A, third row) . Importantly, IF staining for SNAI1 and FN1 were mainly enhanced in the epithelial surface, consistent with EMT formation. Furthermore, VIM and COL1A were more widely distributed throughout the interstitium. The expression of all of these mesenchymal markers were blocked by BMS345541 treatment ( Figure 7A , fourth row), providing further evidence that IKK inhibition effectively blocks chronic poly(I:C)-induced mesenchymal transition, and links this program to pulmonary fibrosis. Hydroxyproline was quantified in whole lung and BALF. *P , 0.05 for each pairwise comparison shown. Data are mean (6SD) for n = 5 animals for each group. Scale bars, 300 mm. COL, collagen; n.s., not significant; SHGM, second harmonic generation microscopy.
At the molecular level, repetitive poly(I:C) stimulation induced the expression of NF-kB-dependent genes (RelA, KC, IL-6) and mesenchymal genes (SNAI1, FN-1, VIM, COL1A1) in total lung RNA ( Figure 7B ). BMS345541 treatment significantly inhibited the chronic poly(I:C)-induced pulmonary fibrotic program ( Figure 7B ). Together, our mechanistic studies using cultured cells and animal models have identified NF-kB as a key regulator of chronic poly(I:C)-induced airway fibrosis and remodeling, providing a new model and pathway for therapeutic intervention for chronic airway diseaseassociated pulmonary fibrosis ( Figure 7C ).
Discussion
The results of our studies indicate an association of chronic activation of the NF-kB pathway downstream of TLR3 /ml. No statistical differences were observed in poly(I:C) treatment or BMS345541 groups (n = 5 mice/group). (D) Effect of BMS345541 on cytokine secretion in BALF. BALF was analyzed for cytokines using multiplex ELISA (n = 5 mice/group). Protein concentration (pg/ml) was determined by reference to internal standards. *P , 0.01 poly(I:C) 1 vehicle versus poly(I:C) 1 BMS345541; **P , 0.01 compared to PBS treatment alone. Data are mean (6SD) for n = 5 animals for each group.
signaling with EMT, airway remodeling, and fibrosis. In support, we observed that poly(I:C) activated expression of the core mesenchymal transcriptional regulators, SNAI1 and ZEB1, as well as fibrotic program in a manner dependent on the IKK-NF-kB pathway, by normal hSAECs. Correspondingly, repetitive poly(I:C) challenge induces dramatic morphological changes in the epithelium and expansion of subepithelial mesenchymal cells, with enhanced COL deposition in the medium and small airways ( Figure 5 ). Linking our cellular studies with the complex responses in the animal model, we observed enhanced expression of SNAI1 and FN1 in the airway epithelial layer, providing evidence that poly(I:C) induces features of the mesenchymal transition that may be associated with airway remodeling ( Figure 7C ). Our results further indicate that the weight loss, cellular remodeling, EMT, and fibrosis induced by poly(I:C) were blocked by BMS345541 treatment, consistent with the conclusion that NF-kB is required for EMT-associated lung remodeling. Together, these data provide insight into the potential mechanisms as to how repetitive viral infections can be linked to airway fibrosis, through the IKK-NF-kB pathway.
Using an in vitro model of telomeraseimmortalized epithelial cells, we have found that NF-kB/RelA is a master mediator of TGF-b-induced EMT (9, 21) . Mechanistically, we know that TGF-b activates NF-kB/RelA through a complex mechanism, initially producing activating serine 276 phosphorylation, followed by the later production of a paracrine factor inducing its translocation through the canonical pathway (28) . In the nucleus, NF-kB/RelA directly up-regulates the core EMT regulators, including SNAI1, Twist family BHLH transcription factor 1, and ZEB1, by binding to their proximal promoter regions and activating their expression by a transcriptional elongation mechanism (28) . hSAECs have many characteristics of primary epithelial cells, in particular the innate pathway coupled to NF-kB activation, and the fact that these features are observed in vivo. Although the NF-kB pathway is highly conserved across epithelial types, our studies linking chronic poly(I:C) activation to mesenchymal transition will need to be validated in future studies with other primary airway epithelial cell types. Although the proinflammatory cytokines, IL-1b, TNFs, and IFNs, have been shown to modulate TGF-b-induced EMT (29) , none of these proinflammatory factors by themselves produces a stable type II EMT. We report, for the first time, that persistent activation of the IKK-NF-kB pathway by viral patterns is sufficient to trigger EMT in cultured hSAECs. Our demonstration that poly(I:C) up-regulates the core regulators, SNAI1, ZEB1, and mesenchymal VIM and FN1 genes, suggests that poly(I:C)-TLR3 signaling activates gene regulatory networks shared with those induced by TGF-b in the prototypical EMT program.
We interpret the robust SNAI1 and FN1 expression-associated enhanced extracellular matrix deposition and myofibroblast transition associated with enhanced interstitial VIM staining to indicate that poly(I:C) induces molecular features of an EMT state in vivo. These chronic inflammatory responses resemble those features of mesenchymal transition observed in bronchial epithelium in patients with severe asthma and COPD (7, 9, 14, 30) . In our repetitive inflammation model, poly(I:C) directly activates epithelial cells, because these cells constitutively express cell-surface TLR3 (31) . More work will be required to examine the role of the epithelium in fibrosis and remodeling.
Airway Fibrosis in Response to Poly(I:C)
Our multimodal imaging studies using micro-CT, a well established approach for quantitative assessment of pulmonary fibrosis (32), SHGM to measure 3D COL deposition patterns, and tissue clearing all indicate that the pattern of fibrosis associated with repetitive poly(I:C) stimulation is heterogeneous. This fibrosis involves the small-and medium-sized airspaces, and is primarily concentrated in the left lung. One explanation for this asymmetric distribution may be anatomical-with the left lung being smaller and less lobulated than the right, enabling intranasal poly(I:C) to preferentially distribute to this side. We note that patterns of bleomycin-induced fibrosis are dependent on its route of administration as well (33) . Our cell culture analysis indicates that poly(I:C) induces a fibrotic gene expression program, including up-regulation of COL1A and FN1, genes the expression of which are both enhanced in the lung. These observations suggest that the epithelium may play multiple roles in poly(I:C)-induced fibrosis-directly, by producing COL1A and FN1, and indirectly through secretion of factors that activate myofibroblasts. Of relevance, Figure 7 . (Continued). goat anti-rabbit IgG (shown in green or red, respectively), counterstained with DAPI, and imaged via fluorescence microscopy. (B). Analysis of the fibrotic and EMT program. Total lung RNA was extracted, purified, and reverse transcribed. The abundance of indicated mRNAs was determined using mouse gene-selective primers (Table 1) . Shown is mean fold change mRNA abundance (6SD) normalized to mouse cyclophilin (mPPIA) for n = 5 animals from each treatment group. (C) Mechanistic linkage of NF-kB activation with mesenchymal transition and airway remodeling. Shown is a schematic model of airway epithelium stimulated with TLR3 agonist. Persistent activation of the NF-kB pathway results in up-regulation of the core EMT regulator SNAI1, as well as enhanced production of extracellular matrix proteins FN1 and Col1A. Expansion of myofibroblast population is indicated by interstitial VIM up-regulation and accumulation of hydroxyproline. Down-regulation of CDH1 results in reduced adherens junctions and enhanced epithelial permeability. **P , 0.01 compared to poly(I:C) 1 vehicle treated mice. ECM, extracellular matrix; EMTU, epithelial-mesenchymal trophic unit; TLR3, Toll-like receptor 3. Our histological studies indicate that poly(I:C) induces broad effects on the airway mucosa, including morphological changes in the epithelium (bronchial epithelial flattening, loss of the brush border), enhanced appearance of glandular cells, as well as expansion of subepithelial fibroblast populations. Epithelial cells constitutively express TLR3 receptors, and consequently respond to extracellular poly(I:C) in vitro (20) and in vivo (31). In our chronic poly(I:C) model, we also think that expansion of the myofibroblast population is seen; this is suggested by an expanded population of subepithelial mesenchymal cells ( Figure 6A ), cells that express VIM ( Figure 7A ). These findings indicate that poly(I:C) activates expansion of the EMTU. Under normal conditions, the EMTU is only a thin layer of subepithelial mesenchymal cells (34) . By contrast, in response to epithelial injury and acute inflammation, the EMTU dynamically expands to assume a secretory phenotype characteristic of myofibroblasts, enhancing subepithelial matrix deposition (35) . Myofibroblast expansion occurs partly in response to intercellular signals released from injured epithelial cells, such as growth factors (TGF-b and epidermal growth factor) and cytokines (periostin, IL-11, IL-17) that promote proliferation, transdifferentiation, and synthesis of extracellular matrix (36) . EMTU expansion may also be the consequence of NF-kB signaling to trigger the IL-6 growth factor (9, 21, 28) . More studies will be required to understand the mediators of mesenchymal expansion in this model. We interpret these observations and literature to mean that epithelial cell state responses may play a central role in the poly(I:C)-induced fibrotic program. Our studies were not designed to identify the origin of the mesenchymal fibroblast population; other studies suggest these may arise from mesenchymal transition of epithelial cells (37) , circulating mesenchymal stem cells, or myofibroblast transition of resident fibroblasts (38) . In addition to the expansion of the myofibroblast population, we observed increased numbers of secretory cells, implicating the presence of goblet cell metaplasia, a process that results from transdifferentiation of ciliated epithelial and Clara cells to mucus-producing goblet cells. Chronic epithelial stimulation with TGF and amphiregulin are thought to be responsible for goblet cell metaplasia (36) . How innate signaling or mesenchymal transition is linked to stem cell expansion and induction of epithelial transdifferentiation programs underlying goblet cell hyperplasia will be of interest to pursue in future studies.
Differences in Response to Acute versus Chronic Mucosal Stimulation
There are few studies available examining the effects of chronic inflammation on airway responses. A potentially important and interesting finding from our study was that repetitive poly(I:C) stimulation, mimicking repeated viral infections, reprograms mucosal signal transduction pathways. Although it has been widely observed that acute poly(I:C) produces a robust inflammatory and antiviral response (20) , our studies here show that chronic poly(I:C) stimulation results in a later gene expression program that resembles TGF-b-induced mesenchymal transition and fibrosis. How could chronic inflammation produce a different response than an acute stimulation? One insight generated using systems-level approaches developed by our group is that the mesenchymal transition itself reprograms intracellular signaling pathways (39) . Mechanistically, this is the result of dramatic changes in kinome and phosphatase expression patterns (40) as a result of the epigenetic reprogramming induced by the transition (9, 13) . Studies on how this mesenchymal transition affects responses to viral RNA patterns are needed. These data are consistent with our previous work, showing that the airway mucosa expression program evolves from an acute inflammation to chronic fibrosis after chronic oxidative DNA damage (41) . We note that TLR3 is also a potent activator of reactive oxygen species signaling (42) , and potentially suggests a role for reactive oxygen species in airway fibrosis, the understanding of which will require further investigation.
Role of Leukocytic Inflammation in Poly(I:C)-Induced Fibrosis
In vivo, poly(I:C) induces perivascular/ peribronchiolar inflammatory infiltrates due to increased cytokine production (22) . Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice (43) , features characteristic of acute viral infections (44) . Neutrophil recruitment is a hallmark of the innate immune response, mediated by release of epithelial-derived chemokines and danger patterns. Of relevance here, NF-kB-driven expression of chemokines, such as CXCL, KC, and granulocyte/macrophage colony-stimulating factor, enhance neutrophil recruitment and survival. Our data suggest that neutrophil-secreted proteases may play important roles in viral pattern-induced airway remodeling. Although we observed persistent elevation of IL-6 at 12 days after the last poly(I:C) challenge, our study was not designed to reveal how changes in profiles of cytokine responses occur after serial challenge.
Relation of Inflammation-Induced Fibrosis to Other Lung Fibrosis Models
Although others have shown that ectopic expression of IL-1 and TNF is sufficient to produce airway fibrosis, a clinically relevant model of viral RNA pattern-induced airway fibrosis has not yet been reported to our knowledge. The gold standard for airway fibrosis has been the bleomycin animal model (45) . The response to bleomycin is typically characterized by acute injury associated with endothelial cell injury and loss of type 1 epithelial cells, followed by proliferation of fibroblasts and the presence of alveolar debris, resulting in inflammation, edema, and release of mediators/inflammatory components. In its final stages, increases in airway neutrophil and lymphocyte numbers (46) , disturbed alveolar structure, accumulation of COL around alveoli, up-regulated expression of COL, and an increase in plasma TGF-b levels result in remodeling and airspace destruction (47) . Although both chronic poly(I:C) and bleomycin models converge on the TGF-b signaling pathway, the initial effect of bleomycin is not via TLR3-mediated signaling, but rather through a toxic response mediated by free-radical formation, cell death, and stromal expansion of fibroblasts (48) . Thus, the applicability of understanding of the EMT and airway remodeling responses in the bleomycin model may be limited.
Relevance of the Model of Chronic Innate Inflammation to Human Airway Disease
Our model of chronic innate inflammation secondary to TLR3-associated stimulation is related to the effect of repetitive airway viral infections. Viral respiratory infections trigger acute innate responses in the airways and are associated with acute respiratory decompensations in patients with underlying asthma (49) , COPD (50) , and cystic fibrosis (51). In particular, infections with the paramyxovirus and respiratory syncytial virus (which occur repeatedly throughout life), are linked to decompensation of airway function and remodeling (17) . Similarly, prospective observational studies have demonstrated that frequent respiratory infections are linked to persistent IL-6 expression, neutrophilia, and declines in forced expiratory volume in 1 second in COPD (52) . We also note that weight loss, a prominent manifestation of our mouse model, is a significant comorbidity in COPD associated with systemic inflammation and cachexia (53) . Thus, our data support that models of viral infection associated with inflammation-induced airway remodeling and fibrosis are important for understanding the pathogenic mechanisms of viral-induced exacerbation of obstructive lung diseases and mediators of cachexia.
Conclusions
Airway remodeling is a multicellular process that causes a progressive decline of pulmonary function. Tissue remodeling has been associated with respiratory virus infections, of which the mechanism(s) is largely unknown. We investigated the effects of persistent activation of the innate immune response on mesenchymal transition in normal airway epithelial cells and in vivo. In vitro, extracellular poly(I:C) triggered an epithelial cell state change characteristic of EMT that was absolutely dependent on activity of the IKK-NF-kB/RelA pathway. In vivo, repetitive activation of TLR3 produced NFkB/RelA-dependent airway remodeling, expansion of the EMTU, mesenchymal transition of epithelial surface, and fibrosis of the proximal and small airways. The consistency of those data across our in vitro and in vivo investigations indicate that this model may be useful for analyzing the role of epithelium in inflammation-induced airway fibrosis and cachexia. n
